HomeNewsBusinessCompaniesCadila to see marginal impact of USFDA warning letter
Trending Topics
Sensex Live
Orkla India IPO
Lenskart IPO Allotment Status
Groww IPO Day 2 GMP
Gold Rate

Cadila to see marginal impact of USFDA warning letter

Chirag Talati, pharma analyst at Espirito Santo Securities tells CNBC-TV18 that since the company does not generate any sales from the facility, and approval of the 18 ANDAs (Abbreviated New Drug Application) were not expected until FY13, FY12 margins will remain intact.

July 06, 2011 / 16:37 IST
Story continues below Advertisement
Remove Ad

Your browser doesn't support HTML5 video.

Cadila Healthcare recently received a warning letter from the US Food and Drug Administration (USFDA) with regard to the company

TAGS: #ANDA #Business #Cadila Healthcare #cGMP #current good manufacturing practice #finished pharmaceuticals #injectible products #US Food and Drug Administration #USFDA
first published: Jul 6, 2011 02:33 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Follow Us On: Facebook twitter instagram linkedin telegram youtube
News
Business New Market New Stocks Income Tax Calculator Election Schedule 2024 India News Economy Mutual Funds Personal Finance IPO News Startups New USA Elections New
Features
Gold Rate Today Silver Rate Today Trending News Startups New National News MC Videos MC You Tube
Tools
SIP Calculator 2 SIP Calculator 3 SIP Calculator 1 New SIP Calculator 4
Specials
PowerYourTrade Master Your Money Game Changers
Network 18 Sites
News18 Firstpost CNN News18 CNBC TV18 Forbes History TV18
Personal Finance
Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker Fixed Deposits Fixed Deposit Comparison Fixed Income Account Aggregator
Quick Links
About Us New Contact Us Advisory Alert New Advertise with Us New Disclaimer Privacy Policy Cookie Policy Terms & Conditions Careers Financial Terms (Glossary) Analytical & Information Tool New
Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.